+086 1911-7288-062 [ CN ]
Cookies give you a personalized experience,Сookie files help us to enhance your experience using our website, simplify navigation, keep our website safe and assist in our marketing efforts. By clicking "Accept", you agree to the storing of cookies on your device for these purposes.For more information, review our Cookies Policy.
Share:
“Our customers need credible sustainability data they can trust and use,” said Thilo Krapfl, head of the Oral Drug Delivery Solutions product line at Evonik. “Life cycle assessments enable us and our customers to make data-driven decisions that improve the sustainability profile of pharmaceutical products and processes."
medical companies are facing rising pressure to decrease their Scope 3 releases and meet evolving environmental, social and governance (ESG) standards. As a result, customers increasingly develop suppliers who offer transparent environmental data and demonstrate efforts to decrease releases across the value chain.
Cradle-to-gate LCAs assess the environmental impact of a product from raw material extraction through production. LCA data from Evonik's certified LCA methodology helps medical companies understand the footprint of excipients, and leverage opportunities to decrease environmental impacts across the value chain.
In the case of EUDRAGIT® L 100-55, the implementation of a state-of-the-art spray drying system at Evonik's Darmstadt site resulted in approximately 6 percent reduction in the PCF compared to the previous set-up. The new spray drying facility is powered by renewable electricity, and its location minimizes transport between production sites.
“Sustainability is a continuous improvement journey,” said Muhammad Irfan, Plant Production Manager at Evonik Health Care. “By using LCA data to identify hotspots, we can focus our improvement efforts where they have the greatest impact – from energy consumption and transport to process efficiency.”
EUDRAGIT® polymers are polymethacrylates suitable to a wide range of drug delivery applications. applied individually or in combination, they enable virtually any target discharge profile, including immediate, delayed and sustained discharge. In addition, selected EUDRAGIT® grades can be applied to solubility enhancement of poorly soluble drug substances. They are compatible with all relevant processing technologies, including hot melt extrusion and spray drying.
LCA data is integral to Evonik Health Care’s sustainability strategy, helping customers develop efficiently medications and treatments while minimizing environmental impacts. Evonik Health Care has the ambition to be climate neutral in Scope 1 and 2 releases and generate greater than 70 percent of its portfolio with Next Generation Solutions by 2030.
We will contact you soon
888CHEM
Japanese 
Korean 
Hindi 
Russian 
Arabic 
Malay 
